Atrin Pharmaceuticals

company

About

Atrin Pharmaceuticals is a privately held biopharmaceutical company that aims to change the way cancer is being treated.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$150K
Industries
Biotechnology,Content Discovery,Medical,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
1 - 10
Operating Status
Active

Atrin Pharmaceuticals is a privately held biopharmaceutical company, based in Doylestown, PA, that aims to change the way cancer is being treated. The company is engaged in the discovery and development of innovative treatments for cancer. The company's most advanced program is focused on a new class of compounds that are highly specific inhibitors of ATR, a key mediator of DNA repair. Atrin is further assembling a pipeline of additional drug candidates, identified via the company's proprietary, human cell-based, high-throughput screening platform, Atrize™. Applicable to both drug discovery/development and the evaluation of patient-specific treatments, Atrize enables the rapid identification and evaluation of compounds that are effective in inhibiting cancer cell viability without adversely affecting healthy cells.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$150K
Atrin Pharmaceuticals has raised a total of $150K in funding over 2 rounds. Their latest funding was raised on Feb 1, 2019 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2019 Series Unknown $150K 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Atrin Pharmaceuticals is funded by 1 investors. Keiretsu Forum are the most recent investors.
Investor Name Lead Investor Funding Round
Keiretsu Forum Series Unknown